• Therapeutic Cataract & Refractive
  • Lens Technology
  • Glasses
  • Ptosis
  • AMD
  • COVID-19
  • DME
  • Ocular Surface Disease
  • Optic Relief
  • Geographic Atrophy
  • Cornea
  • Conjunctivitis
  • LASIK
  • Myopia
  • Presbyopia
  • Allergy
  • Nutrition
  • Pediatrics
  • Retina
  • Cataract
  • Contact Lenses
  • Lid and Lash
  • Dry Eye
  • Glaucoma
  • Refractive Surgery
  • Comanagement
  • Blepharitis
  • OCT
  • Patient Care
  • Diabetic Eye Disease
  • Technology

Valeant proposes Allergan deal

Article

Late yesterday afternoon, Valeant Pharmaceuticals announced that it had proposed a merger with Allergan.

 

Late yesterday afternoon, Valeant Pharmaceuticals announced that it had proposed a merger with Allergan.

Allergan’s largest shareholder (9.7%), Pershing Square Capital Management, managed by Bill Ackman, supports the initiative, according to Bloomberg. In addition, Mr. Ackman believes that Allergan is undervalued and worked with Valeant to cooperatively engage in a hostile takeover of Allergan.

Yesterday, according to the Wall Street Journal, Valeant offered Allergan $48.30 and 0.83 Valeant shares per Allergan share.

Allergan’s stock price was $116.63 on April 10, the day before Mr. Ackman began rapidly accumulating shares. It increased to $166.41 after news broke of Valeant’s interest.

Valeant finalized its acquisition of Bausch + Lomb in August 2013.ODT

Related Videos
Andy Morgenstern, OD, FAAO, FNAP chats with Optometry Times
R Tracy Williams, OD, FAAO with Optometry Times
Shan Lin, MD, speaks on Glaucoma 360 presentation in an interview with Ophthalmology Times
Cecelia Koetting, OD, FAAO, DIPABO, left, speaks with Optometry Times about the 2024 EnVision Summit
Bonnie An Henderson, MD, highlights key takeaways of the 2024 EnVision Summit, including diversity and family inclusion
Danica Marrelli, OD, FAAO, AAO Dipl, co-chair of EnVision Summit chats about geographic atrophy and glaucoma panels
Robert Weiss, former CEO and President of The Cooper Companies, Inc. (left) and Optometry Times' Assistant Managing Editor Emily Kaiser Maharjan Image Credit ©Optometry Times
© 2024 MJH Life Sciences

All rights reserved.